Henrik Schmidt Selected Research

Henrik Schmidt Research Topics

Disease

70	Melanoma (Melanoma, Malignant) 05/2024 - 06/2004
27	Neoplasms (Cancer) 01/2024 - 06/2002
14	Out-of-Hospital Cardiac Arrest 02/2024 - 01/2016
12	Coma (Comas) 01/2024 - 01/2016
11	Heart Arrest (Cardiac Arrest) 12/2023 - 06/2019
10	Inflammation (Inflammations) 11/2023 - 12/2011
8	Myocardial Infarction 04/2024 - 12/2013
8	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2006
7	Cardiogenic Shock 04/2024 - 02/2019
4	Fatigue 01/2023 - 01/2015
3	Brain Injuries (Brain Injury) 02/2024 - 12/2021
3	Hypertension (High Blood Pressure) 02/2024 - 12/2023
3	Fever (Fevers) 01/2024 - 03/2015
3	Wounds and Injuries (Trauma) 01/2024 - 08/2009
3	Shock 01/2022 - 01/2019
3	Nausea 04/2020 - 01/2015
3	Lymphatic Metastasis 01/2019 - 05/2015
3	Heart Failure 02/2018 - 01/2006
2	Hemorrhage 01/2024 - 01/2021
2	Hypotension (Low Blood Pressure) 12/2023 - 12/2021
2	Brain Ischemia (Cerebral Ischemia) 01/2023 - 06/2019
2	Hypoxia (Hypoxemia) 01/2023 - 12/2021
2	Ischemia 01/2023 - 12/2016
2	Diabetes Mellitus 09/2020 - 04/2014
2	Tertiary Lymphoid Structures 01/2020 - 01/2020
2	Colitis 12/2019 - 05/2015
2	Brain Neoplasms (Brain Tumor) 06/2019 - 02/2013
2	Body Weight (Weight, Body) 11/2016 - 01/2015
1	Kidney Diseases (Kidney Disease) 05/2024
1	ST Elevation Myocardial Infarction 02/2024
1	Renal Insufficiency (Renal Failure) 10/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Arthritis (Polyarthritis) 01/2022

Drug/Important Bio-Agent (IBA)

18	IpilimumabIBA 12/2023 - 11/2011
17	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2005
12	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2017
10	NivolumabIBA 12/2023 - 01/2015
9	Lactic Acid (Lactate)FDA LinkGeneric 02/2024 - 01/2018
7	Interleukin-2 (IL2)IBA 01/2019 - 06/2002
6	Formaldehyde (Formol)FDA Link 01/2020 - 12/2004
6	ParaffinIBA 01/2020 - 12/2004
6	CytokinesIBA 01/2017 - 06/2002
5	Oxygen (Dioxygen)IBA 12/2023 - 02/2022
5	InterferonsIBA 01/2019 - 10/2007
4	pembrolizumabIBA 01/2022 - 01/2019
4	Cadherins (E-Cadherin)IBA 01/2019 - 12/2011
4	MART-1 AntigenIBA 11/2015 - 12/2004
4	Messenger RNA (mRNA)IBA 11/2011 - 12/2004
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 08/2016
3	Exenatide (Byetta)FDA Link 01/2018 - 01/2016
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018 - 01/2016
3	Monoclonal AntibodiesIBA 07/2012 - 11/2011
2	Phosphopyruvate Hydratase (Enolase)IBA 02/2024 - 01/2023
2	CreatinineIBA 12/2023 - 04/2014
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 11/2023 - 11/2021
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 10/2022 - 10/2022
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 08/2020
2	trametinibIBA 12/2020 - 01/2019
2	dabrafenibIBA 12/2020 - 01/2019
2	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 01/2015
2	Blood Glucose (Blood Sugar)IBA 09/2020 - 01/2018
2	Transaminases (Aminotransferases)IBA 01/2019 - 11/2010
2	AntibodiesIBA 10/2017 - 08/2016
2	AntigensIBA 01/2017 - 06/2002
2	Histocompatibility Antigens Class IIBA 01/2017 - 06/2002
2	Neuroprotective AgentsIBA 12/2016 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2011
2	Interleukin-6 (Interleukin 6)IBA 10/2012 - 08/2012
2	EnzymesIBA 07/2009 - 02/2006
2	ImmunosorbentsIBA 07/2009 - 02/2006
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2009 - 02/2006
2	Monophenol Monooxygenase (Tyrosinase)IBA 04/2006 - 10/2005
2	S100 Calcium Binding Protein beta SubunitIBA 10/2005 - 06/2004
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2024
1	Fibrinolysin FDA Link 01/2024
1	PlasminogenIBA 01/2024
1	Tranexamic Acid (AMCA)FDA Link 01/2024
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 11/2023
1	C-Reactive ProteinIBA 05/2023
1	Pyruvic Acid (Pyruvate)IBA 01/2023
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 11/2021

Therapy/Procedure

23	Therapeutics 05/2024 - 05/2015
20	Immunotherapy 03/2024 - 06/2002
11	Resuscitation 01/2024 - 06/2019
4	Critical Care (Surgical Intensive Care) 02/2024 - 04/2007
3	Microspheres (Microsphere) 04/2024 - 02/2019
3	Cardiopulmonary Resuscitation (CPR) 02/2024 - 11/2022
3	Aftercare (After-Treatment) 01/2023 - 05/2012
2	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2024 - 10/2023
2	Extracorporeal Membrane Oxygenation 04/2024 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 02/2024 - 10/2022
2	Drug Therapy (Chemotherapy) 12/2019 - 01/2015
2	Induced Hypothermia 01/2018 - 01/2016
1	PRIME protocol 01/2024
1	Catheters 12/2021
1	Percutaneous Coronary Intervention 08/2021
1	Salvage Therapy 01/2021